![In Memoriam: Berrien Moore III [1941–2024]](https://assets.science.nasa.gov/dynamicimage/assets/science/esd/earth-observer/2025/2025-in-memoriam/InMemoriam-Moore..jpg)
![In Memoriam: Jeff Dozier [1944–2024]](https://assets.science.nasa.gov/dynamicimage/assets/science/esd/earth-observer/2025/2025-in-memoriam/InMemoriam-Dozier1.jpg)
Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor
Romvimza, a drug for treating tenosynovial giant cell tumor, was initially developed by Deciphera Pharmaceuticals. Last year, Ono Pharmaceutical acquired Deciphera to build up its oncology portfolio and expand its business prospects in the U.S. and Europe. The post Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor appeared first on MedCity News.
Romvimza, a drug for treating tenosynovial giant cell tumor, was initially developed by Deciphera Pharmaceuticals. Last year, Ono Pharmaceutical acquired Deciphera to build up its oncology portfolio and expand its business prospects in the U.S. and Europe.
The post Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor appeared first on MedCity News.
